Literature DB >> 20652766

Juguloarterial endothelin-1 gradients after severe traumatic brain injury.

Doris A Chatfield1, Darshan H Brahmbhatt, Tilly Sharp, Iain E Perkes, Joanne G Outrim, David K Menon.   

Abstract

BACKGROUND: Endothelin-1 (ET-1) is a potent vasoconstrictor and is thought to be responsible for secondary ischemia and vasogenic edema after traumatic brain injury (TBI). Both CSF and plasma concentrations have been shown to be increased after TBI, but there is little evidence to confirm an intracranial site of production.
METHODS: Using paired arterial and jugular venous bulb sampling, we measured arterial and jugular levels of ET-1 and its precursor, big endothelin (Big ET), and calculated juguloarterial (JA) gradients for the first 5 days post-TBI.
RESULTS: Arterial levels of both Big ET and ET-1 were maximal on day 1 post-TBI, and decreased thereafter (P < 0.05). Arterial levels of Big ET and ET-1 showed correlation across all 5 days of the study (r(2) = 0.25, P < 0.001). While there was no significant JA gradient for Big ET, significant gradients were observed for ET-1 on days 1-4 post-TBI (P < 0.05). There was no correlation between JA gradients for Big ET and ET-1 (r(2) < 0.1, P > 0.9). These data suggest parenchymal production of ET-1 by brain tissue with spill over into the blood, rather than local intraluminal cleavage of Big ET in the cerebral vasculature. Systemic ET-1 levels and JA gradients of ET-1 were unrelated to the injury severity, APACHE II score, Marshall Grade, the presence of subarachnoid or subdural hemorrhage, or eventual outcome.
CONCLUSIONS: These findings confirm the synthesis of Big ET and its cleavage to ET-1 within the brain after TBI. More work is needed to elucidate the pathophysiological role and the outcome impact of ET-1 generation after TBI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20652766     DOI: 10.1007/s12028-010-9413-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  32 in total

1.  Differential glial and vascular expression of endothelins and their receptors in rat brain after neurotrauma.

Authors:  A L Sirén; F Knerlich; L Schilling; H Kamrowski-Kruck; A Hahn; H Ehrenreich
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

2.  The diagnosis of head injury requires a classification based on computed axial tomography.

Authors:  L F Marshall; S B Marshall; M R Klauber; M Van Berkum Clark; H Eisenberg; J A Jane; T G Luerssen; A Marmarou; M A Foulkes
Journal:  J Neurotrauma       Date:  1992-03       Impact factor: 5.269

3.  Guidelines for the management of severe traumatic brain injury.

Authors: 
Journal:  J Neurotrauma       Date:  2007       Impact factor: 5.269

4.  Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat.

Authors:  F C Barone; E H Ohlstein; A J Hunter; C A Campbell; S H Hadingham; A A Parsons; Y Yang; E Shohami
Journal:  J Cardiovasc Pharmacol       Date:  2000-11       Impact factor: 3.105

5.  Involvement of the endothelin receptor subtype A in neuronal pathogenesis after traumatic brain injury.

Authors:  M Sato; L J Noble
Journal:  Brain Res       Date:  1998-10-26       Impact factor: 3.252

6.  The incidence of acute brain injury and serious impairment in a defined population.

Authors:  J F Kraus; M A Black; N Hessol; P Ley; W Rokaw; C Sullivan; S Bowers; S Knowlton; L Marshall
Journal:  Am J Epidemiol       Date:  1984-02       Impact factor: 4.897

7.  Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma.

Authors:  V Seifert; B M Löffler; M Zimmermann; S Roux; D Stolke
Journal:  J Neurosurg       Date:  1995-01       Impact factor: 5.115

Review 8.  Endothelin: 20 years from discovery to therapy.

Authors:  Matthias Barton; Masashi Yanagisawa
Journal:  Can J Physiol Pharmacol       Date:  2008-08       Impact factor: 2.273

9.  Biphasic elevation in cerebrospinal fluid and plasma concentrations of endothelin 1 after traumatic brain injury in human patients.

Authors:  Bernd Maier; Mark Lehnert; Helmut L Laurer; Ingo Marzi
Journal:  Shock       Date:  2007-06       Impact factor: 3.454

10.  Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing's syndrome.

Authors:  G Kirilov; A Tomova; L Dakovska; Ph Kumanov; A Shinkov; A S Alexandrov
Journal:  Eur J Endocrinol       Date:  2003-12       Impact factor: 6.664

View more
  3 in total

Review 1.  Cerebral Microvascular Injury: A Potentially Treatable Endophenotype of Traumatic Brain Injury-Induced Neurodegeneration.

Authors:  Danielle K Sandsmark; Asma Bashir; Cheryl L Wellington; Ramon Diaz-Arrastia
Journal:  Neuron       Date:  2019-08-07       Impact factor: 17.173

2.  Blood Biomarkers in Brain Injury Medicine.

Authors:  William R McBride; Caroline E Conlan; Nicole A Barylski; Amelie C Warneryd; Randel L Swanson
Journal:  Curr Phys Med Rehabil Rep       Date:  2022-02-26

3.  Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury.

Authors:  Ryan P Watts; Ogilvie Thom; John F Fraser
Journal:  J Transplant       Date:  2013-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.